It has been shown that, at sites of infection or tissue damage, CCR5 ligands recruit the ingress and activation of effector cells to release chemokines and to further amplify the pro-inflammatory cascade (Bachelerie et al., 2014). The gene discussed is CCR5; the disease is infection.